BPMC - Blueprint Medicines Corporation (BPMC) CEO Kate Haviland On Q1 2022 Results - Earnings Call Transcript

Blueprint Medicines Corporation (BPMC) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Jenna Cohen - Senior Director and Head of Investor Relations Kate Haviland - Chief Executive Officer Christy Rossi - Chief Operating Officer Philina Lee - Chief Commercial Officer Becker Hewes - MD, Chief Medical Officer Mike Landsittel - Chief Financial Officer Conference Call Participants Marc Frahm - Cowen Dane Leone - Raymond James Elizabeth - Goldman Sachs Reni Benjamin - JMP Securities Brad Canino - Stifel Andrew Berens - SVB Securities Mike Ulz - Morgan Stanley David Lebowitz - Citi Eun Yang - Jefferies Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation

For further details see:

Blueprint Medicines Corporation (BPMC) CEO Kate Haviland On Q1 2022 Results - Earnings Call Transcript